Tsao S C, Sugiyama Y, Shinmura K, Sawada Y, Nagase S, Iga T, Hanano M
Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.
Drug Metab Dispos. 1988 May-Jun;16(3):482-9.
Recent kinetic studies using in situ perfused rat liver suggested that the hepatic uptake of extensively albumin-bound ligands is mediated primarily by direct interaction of the albumin-ligand complex with the hepatocyte surface rather than by the small unbound fraction of ligand, as has been generally believed [Ockner et al., Am. J. Physiol. 245, G13 (1983)]. In order to investigate this mechanism in vivo, rose bengal (RB) was injected iv to the normal and Nagase analbuminemic mutant rats (NAR) and both the pharmacokinetic parameters and the serum protein binding parameters for the two groups were compared. The serum disappearance curves of RB in normal rats and NAR were almost superimposed, and no significant difference in various pharmacokinetic parameters including the hepatic uptake clearance (k12V1) was observed between the two groups. Nevertheless, the unbound fractions of RB in serum were approximately 4-fold (equilibrium dialysis method) and 10-fold (spectrophotometric method) higher than those in normal rats. However, in both groups of rats RB is extensively bound to plasma proteins and more than 99.8% of RB in the plasma exists as the protein-bound form. The intrinsic ability of the two groups of rats to take up unbound RB was compared using isolated liver cells. No significant difference between the two groups was observed in the initial velocity of uptake. From these findings, we concluded that the hepatic uptake of RB is primarily driven by the serum protein-bound form and not by the unbound form and that the serum protein-mediated uptake mechanism of RB was not specific only for serum albumin but also for other serum proteins.(ABSTRACT TRUNCATED AT 250 WORDS)
最近利用原位灌注大鼠肝脏进行的动力学研究表明,与白蛋白广泛结合的配体的肝脏摄取主要是由白蛋白 - 配体复合物与肝细胞表面的直接相互作用介导的,而不是如普遍认为的那样由配体的少量未结合部分介导[奥克纳等人,《美国生理学杂志》245,G13(1983)]。为了在体内研究这一机制,将孟加拉玫瑰红(RB)静脉注射到正常大鼠和长谷无白蛋白血症突变大鼠(NAR)体内,并比较了两组的药代动力学参数和血清蛋白结合参数。正常大鼠和NAR中RB的血清消失曲线几乎重叠,两组之间在包括肝脏摄取清除率(k12V1)在内的各种药代动力学参数上未观察到显著差异。然而,血清中RB的未结合部分比正常大鼠高约4倍(平衡透析法)和10倍(分光光度法)。然而,在两组大鼠中,RB都与血浆蛋白广泛结合,血浆中超过99.8%的RB以蛋白结合形式存在。使用分离的肝细胞比较了两组大鼠摄取未结合RB的内在能力。在摄取的初始速度上,两组之间未观察到显著差异。从这些发现中,我们得出结论,RB的肝脏摄取主要由血清蛋白结合形式驱动,而非未结合形式,并且RB的血清蛋白介导的摄取机制不仅对血清白蛋白具有特异性,对其他血清蛋白也具有特异性。(摘要截短于250字)